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Drosophila melanogaster reveals lipid kinase-dependent effects
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Abstract
Phosphoinositide 3-kinases (PI3Ks) can be divided into three distinct classes (I, II, and III) on the basis
of their domain structures and the lipid signals that they generate. Functions have been assigned to the
class I and class III enzymes but have not been established for the class II PI3Ks. We have obtained the
first evidence for a biological function for a class II PI3K by expressing this enzyme during Drosophila
melanogaster development and by using deficiencies that remove the endogenous gene. Wild-type and
catalytically inactive PI3K_68D transgenes have opposite effects on the number of sensory bristles and
on wing venation phenotypes induced by modified epidermal growth factor (EGF) receptor signaling.
These results indicate that the endogenous PI3K_68D may act antagonistically to the EGF
receptor-stimulated Ras-mitogen-activated protein kinase pathway and downstream of, or parallel to, the
Notch receptor. A class II polyproline motif in PI3K_68D can bind the Drk adaptor protein in vitro,
primarily via the N-terminal SH3 domain of Drk. Drk may thus be important for the localization of
PI3K_68D, allowing it to modify signaling pathways downstream of cell surface receptors. The
phenotypes obtained are markedly distinct from those generated by expression of the Drosophila class I
PI3K, which affects growth but not pattern formation.
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Phosphoinositide 3-kinases (PI3Ks) can be divided into three distinct classes (I, II, and III) on the basis of
their domain structures and the lipid signals that they generate. Functions have been assigned to the class I
and class III enzymes but have not been established for the class II PI3Ks. We have obtained the first evidence
for a biological function for a class II PI3K by expressing this enzyme during Drosophila melanogaster
development and by using deficiencies that remove the endogenous gene. Wild-type and catalytically inactive
PI3K_68D transgenes have opposite effects on the number of sensory bristles and on wing venation phenotypes
induced by modified epidermal growth factor (EGF) receptor signaling. These results indicate that the
endogenous PI3K_68D may act antagonistically to the EGF receptor-stimulated Ras–mitogen-activated protein
kinase pathway and downstream of, or parallel to, the Notch receptor. A class II polyproline motif in PI3K_68D
can bind the Drk adaptor protein in vitro, primarily via the N-terminal SH3 domain of Drk. Drk may thus be
important for the localization of PI3K_68D, allowing it to modify signaling pathways downstream of cell
surface receptors. The phenotypes obtained are markedly distinct from those generated by expression of the
Drosophila class I PI3K, which affects growth but not pattern formation.
Phosphoinositide 3-kinases (PI3Ks) signal to activate down-
stream molecules through the generation, within cellular mem-
branes, of specific lipids that are phosphorylated at the D-3
position of the inositol ring. These lipids function as second
messengers and appear to be involved in processes such as
mitogenesis, cell survival, growth, differentiation, adhesion,
motility, and vesicle trafficking (reviewed in reference 67).
Hence, PI3Ks have been the focus of intensive research. In
multicellular organisms, PI3Ks occur as a family of enzymes
(40, 67). These can be assigned to three separate classes (class
I, class II, and class III) based on their domain structures,
differences in catalytic activity towards defined substrates, and
modes of regulation. For many of the downstream events me-
diated by PI3K activation, the exact nature of the PI3K in-
volved has not been defined.
The class I PI3Ks are heterodimers that associate with cell
surface receptors via an adaptor subunit (reviewed in reference
67). Two class I PI3K subclasses have been identified. The
prototypical class IA PI3Ks are composed of a catalytic p110
subunit and a regulatory subunit. The regulatory subunit con-
tains two SH2 domains that bind phosphotyrosine residues in
specific motifs on activated tyrosine kinase receptors or recep-
tor substrates; this interaction results in translocation of the
associated catalytic activity to its lipid substrates at the mem-
brane. A number of distinct adaptor subunits (50 to 85 kDa)
and p110 subunits (p110, p110, and p110) have been iden-
tified. These show some variation in tissue distribution. The
use of isoform-specific inhibitory antibodies has identified dis-
tinct roles for different p110 isoforms in regulating cell motility
and cytoskeletal changes or in mitogenesis, but these are de-
pendent on both receptor and cell type (reviewed in reference
67). PI3K represents a separate subclass of PI3Ks (class IB)
that is activated by G subunits via a distinct p101 regulatory
subunit (63).
The third class of PI3Ks are homologues of Vps34. The
VPS34 gene was originally identified through studies of mu-
tants defective in sorting proteins to the yeast vacuole, indi-
cating an involvement of this PI3K in protein trafficking (28).
Vps34 also appears to act in an osmotic stress-activated path-
way (22). TheVps34 catalytic subunit associates with a protein
kinase, Vps15, which appears to constitutively localize Vps34
to the Golgi membrane and may play a role in activation of the
lipid kinase. Like the class I heterodimers, the Vps34-Vps15
holoenzyme forms an evolutionarily conserved complex of reg-
ulatory and catalytic subunits responsible for its distinct sub-
cellular localization and substrate specificity. Analogous sort-
ing mechanisms exist in higher eukaryotes, and homologues of
Vps34 have been identified in a range of multicellular organ-
isms, including humans (69) and flies (39).
Class II PI3Ks were originally identified by sequence homol-
ogy with other PI3Ks (40). In Drosophila melanogaster
(PI3K_68D) (40, 44) and Caenorhabditis elegans (CE05832,
encoded by the F39B1.1 gene), a single species is present, while
in mammals three forms have been identified, i.e., PI3K-C2
(also termed mcpk and p170) (20, 44, 68), PI3K-C2 (2, 11),
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and PI3K-C2 (43, 47). PI3K-C2 and PI3K-C2 show an
essentially ubiquitous distribution, while the expression of
PI3K-C2 is restricted, principally to the liver. These proteins
have a modular core comprising four PI3K homology regions:
HR4, a Ras binding domain analogous to those in Raf and
RalGDS that is a member of the ubiquitin-like structural su-
perfamily; HR3, a C2 domain; HR2, a helical domain that is a
member of the ARM repeat structural superfamily; and HR1,
a catalytic domain (40; Flybase report for Pi3K68D/CG11621,
http://fly.ebi.ac.uk:7081/.bin/fbidq.html?FBgn0015278). In con-
trast to class I PI3Ks, a Ras-binding function has not been
demonstrated for a class II PI3K (2). Class II PI3Ks are larger
than other PI3Ks (PI3K_68D is 210 kDa) due to extensions at
both the amino and carboxy termini. The C terminus contains
a PX (NADPH oxidase homology) domain (48) and a further,
characteristic, C2 domain. Within the N-terminal region some,
but not all, class II members also contain one or more polypro-
line motifs which may mediate interactions with SH3 or WW
domains. The functions of the class II-specific sequences are
unclear. In some molecules, C2 domains mediate interactions
that are regulated by calcium ions (58). Both C2 domains in
class II PI3Ks, however, lack the critical aspartate residues that
form the calcium binding pocket (40). Thus, analysis of the
primary sequence has provided few clues as to the function and
regulation of this class of enzymes. In particular, a regulatory
subunit has not been identified, and little is known about how
these PI3Ks are activated or the biological processes that they
control.
Studies on class II PI3Ks in mammalian cells have focused
on signaling pathways which have been shown, using inhibitors,
to involve a PI3K; some of these do not seem to be mediated
by the known class I enzymes. Thus, PI3K-C2 has been re-
ported to lie downstream of the monocyte chemotactic pep-
tide-1 chemokine receptor (66), the insulin receptor (12), and
the epidermal growth factor (EGF) receptor (EGFR) (3).
PI3K-C2 can be activated following stimulation of the inte-
grin IIb3 with fibrinogen (74) and has been reported to be a
target of the activated receptors for EGF and platelet-derived
growth factor (3) and to associate with the stem cell factor
receptor, c-kit (4). In each of these cases the biological process
involved appears to require signaling by both class I and class
II PI3Ks.
The three classes of PI3Ks differ in substrate specificity. In
vitro, class I PI3Ks have a broad substrate specificity, phos-
phorylating the phosphoinositides (PIs) PI, PI4P, and
PI(4,5)P2 at the D-3 position. In vivo, however, the major lipid
signal generated by the class I enzymes is believed to be
PI(3,4,5)P3, which can interact with specific pleckstrin homol-
ogy domains in target proteins such as phosphoinositide-de-
pendent kinase 1 and protein kinase B. These protein kinases
appear to mediate many of the processes in which class IA
PI3Ks have been implicated (reviewed in reference 67). In
contrast, class III enzymes only phosphorylate PI to generate
PI3P, consistent with a short activation loop which may be
insufficient to accommodate the more highly phosphorylated
PI substrates (70). PI3P can interact with FYVE fingers. This
motif is commonly found in proteins which function at endo-
somes (reviewed in reference 67). The class II enzymes lack the
critical lysine residue which, in class I enzymes, contacts the 5
phosphate of PI(4,5)P2 (70); hence, they can generate PI3P
and PI(3,4)P2 in vitro, but neither the signal generated in vivo
nor its protein targets have been defined. Each of the three
classes of PI3K can thus generate a different spectrum of
3-phosphorylated lipids, clearly providing the potential to sig-
nal to distinct targets.
Functional analyses of PI3Ks have been complicated by the
presence of multiple members of each class in mammalian
cells. In contrast, Drosophila has only one member of each of
the three classes (40). These are named after their chromo-
somal location: class I is Dp110/PI3K_92E, class II is
PI3K_68D, and class III is DVps34/PI3K_59F. Analysis of the
function of each Drosophila PI3K may, therefore, indicate the
prototypical function of each class of enzyme. Of particular
interest are the class I and class II PI3Ks, since these are
restricted to multicellular organisms and may thus participate
in signaling between cells.
As an unbiased method of identifying cellular processes in-
volving class II PI3K signaling, we have looked at the effects of
expressing PI3K_68D within Drosophila imaginal disks. These
are sheets of epithelial cells that are set aside within the em-
bryo and which proliferate, grow, and pattern during larval life.
Reorganization of these cells during metamorphosis generates
the adult cuticular structures, such as the wings and eyes (16).
Many of these structures are not essential for viability under
laboratory conditions, and hence severe developmental defects
can still be studied. Drosophila thus represents an ideal system
in which to generate phenotypes by targeted expression. In this
study we have used both wild-type and catalytically inactive
versions of PI3K_68D in order to identify effects that are
dependent on the lipid signal. We found that ectopic expres-
sion of wild-type and mutated versions of PI3K_68D in the
larval imaginal disks affected the development of the wing
veins, the wing margin, and the number of external sense
organs. These results suggested a role for this PI3K in signaling
pathways affecting patterning, and we describe genetic inter-
actions with the EGF receptor and Notch pathways. In con-
trast, class I PI3Ks affect growth but not patterning (37). These
results provide the first evidence for different roles for class I
and class II PI3Ks in vivo and indicate that the lipid signals
produced by these separate classes have distinct biological
targets.
MATERIALS AND METHODS
Fly stocks. Gal4 was expressed ubiquitously under the control of the heat
shock promoter; in the wing pouch (especially the dorsal region) by using Gal4-
MS1096 (13), an insertion in the Beadex gene (42); in a stripe along the A/P
boundary and at lower levels in the A compartment by using Gal4-ptc (559.1)
(29); and in epidermal cells by using Gal4-69B (9). UAS-Dp110 (37) and UAS-
tor4021-EGFR (21) have been described previously. UAS-aos (54) was kindly
provided by Mandy Simcox. An activated form of the EGFR (EGFRElpE1)
hypomorphic (drk10626) (60) and antimorphic (drke0A) (59) alleles of drk, the
loss-of-function mutations in Notch (N264-39 and notchoid), and the deficiencies
Df(3L)vin2, Df(3L)vin3, Df(3L)vin4, Df(3L)vin6, and Df(3L)vin7 (1, 17) were
obtained from Kathy Matthews at the Bloomington Stock Center. Df(3L)vin66
was provided by Christian Lehner. Dp110A, a deletion of the PI3K_92E gene, has
been described previously (72).
Plasmid constructs. Constructs were verified by their restriction sites and by
sequence analysis with an Applied Biosystems 373A automated DNA sequencer.
All PCR-amplified sequences were confirmed by sequencing. Sequences of the
oligonucleotides used for PCR and site-directed mutagenesis are available upon
request from the corresponding author.
PI3K_68D constructs. All numbering of amino acids or nucleotides is from the
initiating methionine (M1) or ATG (A1TG) in the PI3K_68D cDNA.
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Plasmids carrying PI3K_68D (WT-PI3K_68D) and a catalytically inactive vari-
ant (KD-PI3K_68D) were generated in the pUAST vector, in which cDNAs are
expressed under the control of five Gal4 binding sites (9). An N-terminal tag for
the c-myc epitope (EQKLISEEDL) was incorporated. This is recognized by the
monoclonal antibody 9E10 (23). The tag was introduced by using the BamH1
cassette in pSK (pSK-68D) (40) as a template. The myc-tagged cassette
(pSKmyc68D) was then digested with BamHI and inserted into the BglII site of
pUAST.
To generate the catalytically inactive PI3K_68D construct, Asp1457 (GAC)
within the kinase domain was mutated to Ala (GC4370C) by using pSKmyc68D as
a template and the Chameleon double-stranded site-directed mutagenesis kit
(Stratagene). The EcoRV site (GATATC) was also altered (GT3354TATC) to
facilitate selection of the mutated plasmid. The BamHI cassette incorporating
the mutation was then inserted into the BglII site of pUAST. The same approach
was used to introduce mutations (P407A, P410A, and R412Q) in the polyproline
motif PPPLPPR to generate pSKmyc68DPII.
An EcoRI cassette incorporating the wild-type sequence was also generated by
the PCR overlap extension method (30). Primers were used to mutate the two
internal EcoRI sites (A4956G and A4965G) and to introduce an EcoRI site 3 to
both the stop codon and 3 BamHI site. A 1.4-kb fragment incorporating these
changes was amplified, digested with XhoI and Asp718, and exchanged for the
Xho-Asp718 fragment in myc-tagged pUAST PI3K_68D.
To generate an amino-terminal fragment of PI3K_68D (N-PI3K_68D) con-
taining the polyproline motifs R123MQPtNP129 and P455PPLPPR461, a 1,446-bp
fragment corresponding to the first 470 amino acids of PI3K_68D was amplified
from the WT-PI3K_68D construct (described above). A 5 NdeI site and a 3
XhoI site were introduced. The fragment was digested with these restriction
enzymes and inserted into the same sites in the pET-16 His tag expression
vector (Novagen). An amino-terminal fragment, NPII-PI3K_68D, containing mu-
tations in the second polyproline motif PII (P407A, P410A, and R412Q) was
generated in the same manner but with pSKmyc68DPII as a template. Mutations
in the first polyproline motif, PI (R123Q, P126A, and P129A) were introduced in
the N-PI3K_68D fragment by using the PCR overlap extension method to gen-
erate NPI-PI3K_68D. A further construct incorporating mutations in both
polyproline motifs, NPI; PII-PI3K_68D, was generated by using the PCR overlap
extension method with the singly mutated templates.
Generation of recombinant GST-SH3 fusion proteins. The glutathione S-
transferase (GST)–Drk, GST-DrkW36A, and GST-DrkW189A constructs were
generously provided by Tony Pawson (46, 50). The GST-DrkW36A;W189A plasmid
was produced by the double ligation of a 304-bp BamHI-BglI fragment (from the
plasmid for GST-drkW36A) and a 331-bp BglI-EcoRI fragment (from the plasmid
encoding GST-DrkW189A) into the pGEXKT vector (Pharmacia) digested with
BamHI and EcoRI. Plasmids encoding GST fusion proteins for the individual
SH3 domains of Drk (N-terminal SH3, amino acids 1 to 72; C-terminal SH3,
amino acids 154 to 211) were generated by PCR amplification with the GST-Drk
construct as a template. The amplified fragments were digested with BamHI and
EcoRI and inserted into the same sites in the pGEXKT vector.
The GST-p120 RasGAP SH3 domain was generated by Simon Woodcock
from p120 RasGAP (24) and provided by David Hughes.
Plasmids encoding GST fusion proteins for the individual SH3 domains of
Src64B (SwissProt accession number P00528; amino acids 96 to 158); Abl
(SwissProt accession number P00522; amino acids 196 to 270); DPLC/small
wing (sl) (Protein Identification Resource accession number A53970; amino
acids 824 to 890); -spectrin (SwissProt accession number P13395; amino acids
970 to 1043), and H-spectrin/karst (kst) (Protein Identification Resource acces-
sion number A37792; amino acids 835 to 916) were generated by PCR amplifi-
cation. First-strand cDNA, prepared from Drosophila poly(A) RNA as de-
scribed previously (40), was used as a template. Restriction sites were
incorporated at the 5 (EcoRI) and 3 (XhoI) ends to facilitate subcloning into
these sites in the pGEXKG vector (26).
Southern hybridizations. Genomic DNA was digested with XhoI, fractionated
on 0.8% agarose gels, and transferred to Hybond N (Amersham). Probes
corresponding to the 5 and 3 ends of the PI3K_68D coding sequence (nucle-
otides 26 to 1063 and  5116 to 5979, respectively, numbered relative to
the coding sequence) were generated by PCR and labeled to the same specific
radioactivity with [-32P]dCTP by using a Multiprime kit (Amersham). Radio-
active bands (5.7-kb 5 fragment and 	4.5-kb 3 fragment) were detected and
quantified with a PhosphorImager (Molecular Dynamics). Since the deficiency
stocks are heterozygous, those which deleted the PI3K_68D gene gave a signal
with half the intensity of an Oregon R control. Values were normalized between
samples by using a probe for the Dp110 gene, PI3K_92E, which maps to a
separate region of the Drosophila chromosome.
Generation of transformants. Transgenic flies were generated by injecting
Qiagen-purified plasmid DNA into yw embryos and selected on the basis of
expression of the mini-white gene (7). For upstream activating sequence (UAS)
constructs, several independent lines were generated for each plasmid to rule out
insertion-specific effects. We found that different insertions for the same con-
struct induced similar phenotypes with different degrees of severity.
Biochemical analyses. (i) Expression of transgenes. Heat shock Gal4-induced
expression of UAS transgenes was achieved by incubating adult flies at 37°C for
1 h and then at 25°C for 4 to 6 h. Flies were lysed in 20 mM HEPES (pH 7.5)–150
mM NaCl–2 mM EGTA–1.5 mM MgCl2–10% (vol/vol) glycerol containing 1%
(wt/vol) Triton X-100, 0.1% -mercaptoethanol, 5 mM benzamidine, 0.2 mM
phenylmethylsulfonyl fluoride, and 100 mU of aprotinin (Sigma) ml1. To main-
tain the phosphorylation state of the Drosophila EGFR (DER), the protein
phosphatase inhibitors sodium orthovanadate (1 mM), -glycerophosphate (10
mM), molybdate (1 mM), tetrasodium pyrophosphate (1 mM), and sodium
fluoride (10 mM) were included. Lysates were clarified by centrifugation.
(ii) Expression of recombinant fusion proteins in bacteria. Escherichia coli
DH5 cells containing plasmids encoding the GST fusion proteins were grown to
an optical density at 600 nm of 0.6. Expression of the fusion proteins was induced
at 27°C with 0.4 mM IPTG (isopropyl--D-thiogalactopyranoside) for 4 h. Bac-
terial pellets were sonicated in phosphate-buffered saline lysis buffer (140 mM
NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 1.8 mM KH2PO4 [pH 7.3]) containing 1%
Triton X-100, 2 mM EDTA, 5 mM benzamidine, 0.2 mM phenylmethylsulfonyl
fluoride, and 0.1% mercaptoethanol and clarified by centrifugation. The extract
was incubated with glutathione-agarose (Pharmacia) beads for 1 h at 4°C with
rotation and washed three times with lysis buffer.
Expression of amino-terminal fragments of PI3K_68D was performed in
BL21(DH3) cells essentially as for the GST fusion proteins.
(iii) In vitro binding assays. Clarified extracts from flies and bacteria were
incubated with immobilized GST or GST fusion proteins (20 
g) for 2 h at 4°C
with rotation. Complexes bound to the beads were recovered by centrifugation,
washed three times with lysis buffer, and heated to 95°C for 5 min in sodium
dodecyl sulfate (SDS) sample buffer.
(iv) Immunoblotting. Extracts were resolved on SDS-polyacrylamide gels,
transferred to nitrocellulose, and incubated with 9E10 to detect the Myc epitope.
For analysis of wild-type and catalytically inactive PI3K_68D, blots were incu-
bated with 9E10 mouse ascites (1/10,000; Developmental Studies Hybridoma
Bank) and detected with horseradish peroxidase-linked anti-mouse immunoglob-
ulin G (1/1,000; DAKO) by using ECL (Amersham). For analysis of complexes
bound to GST fusion proteins, detection was with horseradish peroxidase-cou-
pled anti-mouse IgG (1/10,000; Pierce) and the SuperSignal West Pico chemi-
luminescent substrate (Pierce).
(v) Assay of PI3K activity. PI3K assays were performed as described previously
(40), using PI (Sigma) as a substrate, and resolved by thin-layer chromatography
in chloroform–methanol–4.9 M ammonium hydroxide (50:39:11). The radioac-
tivity was detected with a PhosphorImager (Molecular Dynamics).
Adult phenotypic analyses. Wings from female flies were dehydrated in eth-
anol and mounted in Euparal (Agar Scientific). Images were collected with a
Leaf Microlumina color charge-coupled device camera (ISS, Greater Manches-
ter, United Kingdom).
RESULTS
Analysis of class II PI3K function by ectopic expression. To
identify the biological function of the class II PI3K in a mul-
ticellular organism, we expressed wild-type and mutated ver-
sions of PI3K_68D in different patterns during Drosophila
imaginal disk development and looked for phenotypes in the
adult cuticle. cDNAs for PI3K_68D were fused to an epitope
tag and cloned into P-element expression vectors under the
control of yeast Gal4 UASs (9).
Ectopic expression of the class I and class II PI3Ks gener-
ates distinct phenotypes. Ectopic expression of the class I
PI3K, Dp110, has been shown to enhance organ size by in-
creasing the size of cells without perturbing patterning (37, 72).
To evaluate differences between the two classes of PI3Ks, the
effects of their expression were directly compared by using a
promoter that drives expression at high levels within the pro-
spective wing blade. The wing is a flat structure, and hence
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changes in size can be easily visualized. The two PI3Ks gener-
ated distinct phenotypes (Fig. 1), indicating that class I and
class II PI3Ks target distinct pathways. Ectopic expression of
the class I PI3K generated a larger wing, as has been previously
described (37). In contrast, ectopic expression of the class II
PI3K, PI3K_68D, generated very severe developmental de-
fects. When larvae were reared at 18°C rather than at 25°C to
induce weaker expression of PI3K_68D, the phenotypic effects
obtained were less severe although variable. An example of a
weak phenotypic effect is shown in Fig. 1C. Effects on the
patterning of the wing veins were observed. In addition, many
of the wings were blistered, presumably because the two sur-
faces of the wing blade failed to adhere properly. In contrast to
ectopic expression of the class I PI3K, overgrowth of the wing
never occurred with ectopic PI3K_68D expression.
While these phenotypes provided a dramatic illustration of
the differences in signaling between the class I and class II
PI3Ks, those generated by expression of PI3K_68D were too
severe and variable to look for genetic interactions with other
signaling components. We therefore also generated a version
of PI3K_68D that was predicted to be inactive, in order to
determine the effects of decreasing the level of class II PI3K
signaling. This construct contained a mutation in an aspartate
residue (D1457A) that lies within the activation loop of the
PI3K catalytic domain and is predicted to contact a metal ion
(70). The corresponding residue within protein kinases has
been shown to be critical for catalytic activity.
The biochemical properties of these proteins were assessed
following heat shock-induced expression in adult flies. The
ectopically expressed PI3K was specifically immunoprecipi-
tated from detergent lysates, using an antibody to the epitope
tag, and assayed for lipid kinase activity. Figure 2A shows that
expression of the wild-type, p210, PI3K (WT-PI3K_68D) was
induced following heat shock and that this protein possessed
PI3K activity. As anticipated, the construct containing the
D1457A mutation lacked detectable PI3K activity when ex-
pressed at levels similar to those of the wild-type protein. We
have designated this transgene KD-PI3K_68D (for kinase
dead). Since the mutant PI3K is unable to generate the down-
stream lipid signal, it is predicted to have an inhibitory or
dominant-negative effect on the function of the endogenous
PI3K by competing with the endogenous PI3K for binding sites
on interacting molecules. Hence, expression of the wild-type or
catalytically inactive PI3K_68D constructs should increase or
decrease the levels of the lipid signal, respectively.
Ectopic expression of wild-type or catalytically inactive ver-
sions of PI3K_68D have opposing effects on bristle number. In
order to generate adult phenotypes, these PI3K_68D trans-
genic lines were crossed to a number of different enhancer-trap
Gal4 lines to induce expression in specific developmental pat-
terns within the larval imaginal disks. We have previously dem-
onstrated that the endogenous enzyme is expressed and pos-
sesses lipid kinase activity at this developmental stage (40).
The expression domain of the patched (ptc) Gal4 line (29,
33) includes the scutellum, the shield-shaped structure at the
base of the thorax. Expression of the WT- and KD-PI3K_68D
transgenes with Gal4-ptc produced opposing and completely
penetrant effects on the number of scutellar bristles (Fig. 2B to
D). Enhancing the level of the lipid signal with the wild-type
transgene resulted in a loss of bristles and was accompanied by
a reduction in the size of the scutellum (Fig. 2C), while de-
creasing the level of the lipid signal with the KD transgene
increased the number of the scutellar bristles (Fig. 2D). Hence,
expression of catalytically active and inactive versions of
PI3K_68D can elicit opposing phenotypic effects. Consistent
with the effects of the class I PI3K on growth but not on
patterning, expression of either wild-type or catalytically inac-
tive versions of Dp110 with Gal4-ptc had essentially no effect
on the number of scutellar bristles (results not shown).
Expression of the class II PI3K affects patterning of the
wing imaginal disk. The Gal4 line 69B induces strong expres-
sion within the epidermis. Staining with a -galactosidase re-
porter line and with an antibody to the Myc epitope, which
FIG. 1. Ectopic expression of the class I PI3K affects organ size,
while ectopic expression of the class II PI3K affects patterning. Wings
of a female control fly (Gal4-MS1096/) (A) or of female flies ex-
pressing wild-type Dp110 (Gal4-MS1096/; UAS-WT-Dp110/)
(B) or PI3K_68D (Gal4-MS1096/; UAS-WT-PI3K_68D/) (C and
D) in the precursor to the wing blade are shown. Crosses were per-
formed at 25°C (A, B, and D) or 18°C (C).
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identifies expression of the PI3K transgene, showed that Gal4-
69B promoted expression within imaginal disks, such as the
wing, haltere, and leg disks, and a restricted expression within
the eye disks (reference 9 and data not shown). Within the
wing disk, expression appeared to be highest in regions that
give rise to the wing margin and within parts of the wing blade
and hinge. We describe phenotypes generated with Gal4-69B
and the PI3K_68D transgenes in the wing imaginal disk that
affected the specification of the wing veins, wing margins, and
sensory elements and the apposition of the wing surfaces.
The adult wing blade consists of two layers of ectodermal
cells (dorsal and ventral) and is divided into regions of vein and
intervein tissue by five longitudinal veins composed of more
compact, highly pigmented cells (Fig. 3A). The veins provide
structural support and form channels for neurons and trachea.
The wing is further characterized by sensory organs such as the
campaniform sensillae on the wing. These pattern elements,
the sensory organs and veins as well as the large sensory bris-
tles (macrochaetae) on the notum, occur in very precise loca-
tions (reviewed in reference 61). These are defined within the
imaginal disks largely by the spatially restricted domains of
expression of the proneural genes, achaete and scute, and the
FIG. 2. Lipid-kinase-dependent phenotypic effects generated by
expression of PI3K_68D. (A). Mutation of Asp1457 to Ala within the
active site of PI3K_68D generates a catalytically inactive protein. De-
tergent lysates were prepared from adult flies expressing UAS-
PI3K_68D constructs under the control of Gal4-heat shock promoters.
The extracts were immunoprecipitated with an antibody to the Myc
(9E10) epitope and assayed for PI3K activity with PI as a substrate.
Equivalent levels of the two constructs were induced as shown by
immunodetection with 9E10, but only the wild-type construct pos-
sessed PI3K activity (lane 2). Flies were of the following genotypes:
lane 1, Gal4-hs/CyO; lane 2, Gal4-hs, UAS-WT-PI3K_68D/CyO; lane 3
Gal4-hs/TM3; lane 4, Gal4-hs, UAS-KD-PI3K_68D/TM3. Arrows
mark the positions of the PI3K_68D protein at	210 kDa, of PI3P, and
of the origin. For each sample the equivalent of 0.5 or 2 female flies
were used for the immunoblot (from extracts) and for the PI3K assay
(from immunoprecipitations), respectively. Similar results were ob-
tained in three separate experiments. (B to D) Ectopic expression of
PI3K_68D affects the number of scutellar sensory bristles in a PI3K-
dependent manner. Images of the thoraxes of adult female flies of
genotypes Gal4-ptc/ (B), Gal4-ptc/UAS-WT-PI3K_68D (C), and
Gal4-ptc/; UAS-KD-PI3K_68D/ (D) are shown. The mean number
of scutellar bristles for n  40 nota is shown. The scutellum is indicated
by a bracket. Normally, the four scutellar bristles point distally. In
panel D some of these bristles remain curved upwards as in late stages
of normal pupae, presumably because they fail to reorient themselves
when the flies emerge. Crosses were performed at 25°C.
FIG. 3. Adult wing phenotypes generated by PI3K_68D transgenes
with Gal4-69B. (A) A control wing expressing the Gal4-69B promoter
alone generates an essentially wild-type wing characterized by five
longitudinal veins (L1 to L5), two cross veins (anterior [acv] and
posterior [pcv]), and a number of sensory elements, including the
campaniform sensillae (A and G) on the distal portion of L3 (L3-1 to
L3-3). (B) Expression of WT-PI3K_68D transgenes produced a small
hole (arrow) within the proximal part of the first basal cell in the hinge
region. This unusual phenotype was completely penetrant (at 25°C)
and was observed with six different insertions. Frequently a hole was
also observed in the haltere (not shown). (C to F) Most flies expressing
KD-PI3K_68D under control of the Gal4-69B promoter produced mild
ectopic wing vein material (C), but in a proportion of flies (D to F) a
more severe range of patterning defects was observed. In panel D, a
single ectopic cross vein (arrow) is produced between the distal end of
L2 and vein L3. In panel E, multiple ectopic cross-veins are formed
and there is a thickening of the longitudinal veins in the anterior
region. Panels E and F show losses of portions of the wing margin. In
panel E, the sensory bristles associated with the anterior wing margin
occur at a higher density in the region proximal to the wing margin
loss. (G and H) Section of L3 distal to the anterior cross vein which
carries the L3-1 to L3-3 campaniform sensillae (see panel A). Flies
expressing KD-PI3K_68D show supernumary campaniform sensillae
(arrows) (H) compared to controls (Gal4-69B only) (G). The wings
shown are from female flies of genotypes Gal4-69B/ (A and G),
WT-PI3K_68D/; Gal4-69B/ (B), and Gal4-69B/UAS-KD-
PI3K_68D (C to F and H). Anterior is up; proximal is to the left.
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vein-promoting gene, veinlet (also known as Rhomboid-1). vein-
let encodes a Golgi protein that regulates cleavage and hence
the biological activity of the DER ligand, Spitz (36). In the
third-instar wing disk, veinlet promotes the spatially restricted
activation of mitogen-activated protein kinase (MAPK) by
DER, and this directs wing cells into a vein specification path-
way (64). During pupal development MAPK signaling is
switched off in the prospective vein cells, allowing their differ-
entiation (41), and the pattern is refined by the Notch and
decapentaplegic signaling pathways, which restrict veins to
their characteristic widths (18).
Ectopic expression of the WT-PI3K_68D with Gal4-69B
principally affected structures derived from the wing imaginal
disk, which gives rise to the wing blade, hinge, and notum
(dorsal thorax), although effects on the legs and halteres were
also observed. The hinge region, which joins the wing blade to
the notum, was particularly sensitive to perturbations. WT-
PI3K_68D expression resulted in a “held-out” wing phenotype
that was accompanied by a small hole in the hinge intervein
(Fig. 3B). Although many mutations produce a held-out wing
phenotype, this is not accompanied by the small hole charac-
teristic of PI3K_68D overexpression. Holes in the proximal
part of the wing have been reported for overexpression of the
Rotund RacGap and have been attributed to defects in adhe-
sion (27). Higher levels of expression of WT-PI3K_68D addi-
tionally affected patterning of the wing blade and produced
blisters, as with Gal4-MS1096 (Fig. 1), and occasionally re-
sulted in complete loss of the wing blade itself. With high levels
of WT-PI3K_68D, effects on viability were also observed, pre-
sumably because of expression within the embryo.
At 25°C, most flies expressing the catalytically inactive ver-
sion of PI3K_68D with the Gal4-69B driver showed very minor
amounts of additional wing vein material (Fig. 3C). However,
a small proportion of the progeny displayed more severe phe-
notypes affecting the specification of wing veins and wing mar-
gins (Fig. 3D to F). The penetrance of these phenotypes was
increased when the larvae were reared at 29°C, consistent with
the established temperature sensitivity of the Gal4-UAS sys-
tem (Table 1). This results in higher expression of transgenes
with increased temperature. The effects on wing veins were
most prominent in anterior regions of the wing and were fre-
quently accompanied by a change in the wing shape resulting
from a reduction in the size of anterior intervein regions (see,
e.g., Fig. 3E). In some cases only a single ectopic cross vein
formed between the distal end of L2, where it meets the an-
terior margin, and L3 (Fig. 3D); in others more extensive
ectopic wing venation occurred (as in Fig. 3E). KD-PI3K_68D
expression also affected wing margin formation, resulting in
losses of portions of either the posterior wing margin (Fig. 3F)
or the anterior wing margin with the concomitant loss of mar-
gin bristles (Fig. 3E).
Expression of KD-PI3K_68D also affected the external sense
organs on the wing and thorax. The campaniform sensillae are
dome-shaped sensory structures which are believed to sense
strain on the wing cuticle (Fig. 3G). Expression of KD-
PI3K_68D increased the number of the campaniform sensilla
(Fig. 3H). As with the Gal4-ptc driver (Fig. 2D), Gal4-69B-
mediated KD-PI3K_68D expression also generated supernu-
mary bristles on the thorax (results not shown).
Specific mutations in components of the EGFR and Notch
signaling pathways also affect wing veins, wing margins, and
sensory structures, suggesting a link between these pathways
and PI3K_68D signaling.
Class II PI3K interacts genetically with the EGFR and
Notch signaling pathways. The dosage sensitivity of KD-
PI3K_68D expressed with the Gal4-69B promoter allowed us
to use this combination to look for interactions with genes that
give similar mutant overexpression phenotypes. This approach
can be used to identify signaling pathways in which the class II
PI3Ks might be involved. The observed effects on the specifi-
cation of wing veins and wing margins suggested links with the
EGFR and Notch signaling pathways. The results in Fig. 4
demonstrate that wild-type and catalytically inactive PI3K_68D
transgenes can interact genetically, and in an opposing fashion,
with components of the EGFR signaling pathway in wing vein
development. Furthermore, catalytically inactive PI3K_68D
showed interactions with the Notch pathway.
Ellipse (EgfrElpE1) is a weak hypermorph of DER in which
the first amino acid of the kinase domain (A887T) is mutated
(38). In transfected cells, this change results in ligand-indepen-
dent autophosphorylation of the receptor. In the wing this
mutation is associated with a weak extra-vein phenotype (6,
38). The ability of WT- and KD-PI3K_68D expression to mod-
ify EgfrElpE1-induced phenotypes was assessed. While a single
copy of EgfrElpE1 did not affect ectopic cross vein formation
(Fig. 4D), when combined with the KD-PI3K_68D transgene it
enhanced the penetrance of the formation of an ectopic L2-L3
cross vein from 5% (Fig. 4B) to 100% (Fig. 4E) of the progeny
at 25°C. Conversely, one copy of the EgfrElpE1 chromosome in
combination with WT-PI3K_68D resulted in the loss of the
anterior and posterior cross veins in a significant proportion of
flies (Fig. 4F). These results show that the phenotype of a DER
gain-of-function mutation can be enhanced by a catalytically
inactive PI3K_68D and suppressed by a catalytically active
PI3K_68D.
Argos is a secreted inhibitor of DER (reviewed in references
14 and 52). Ectopic expression of argos by using the Gal4-69B
driver mimics loss-of-function mutations in DER. In the wing
this results in the loss of wing veins, particularly L4 and the
anterior cross vein, and a change in shape resulting from a loss
of intervein tissue (Fig. 4G) (54). In addition, regions of L3
may be lost, and there is a prominent rough eye phenotype and
a loss of the ocelli (simple eyes) and associated bristles on the
head (reference 54 and data not shown). Coexpression of KD-
PI3K_68D restored L4 to the wild-type pattern (Fig. 4H) with-
out affecting the eye or ocelli phenotypes, while coexpression
of the wild-type transgene enhanced the wing vein loss (Fig. 4I)
with complete or partial loss of all veins except L5. Flies ex-




Ectopic cross vein L2-L3 5 25
Extensive ectopic wing venation 5 20
Wing margin loss 2 20
a The single cross vein L2-L3 phenotype is as shown in Fig. 3D.
b Flies were raised at the indicated temperatures. Values are for 100 flies at
25°C and for 41 flies at 29°C.
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pressing argos and WT-PI3K_68D retained the prominent eye
and ocelli phenotypes from argos expression and the hole in
the hinge region generated by WT-PI3K_68D expression.
Thus, targeted expression of WT-PI3K_68D enhanced and that
of KD-PI3K_68D suppressed the wing vein loss generated by
Argos, an inhibitor of the EGFR signaling pathway.
The wing margin forms at the dorsoventral compartment
boundary following expression of transcription factors such as
vestigial and cut, which are induced in response to Notch and
wingless signaling. Consistent with this, specific loss-of-func-
tion mutations in Notch result in loss of parts of the wing
margin (Fig. 4J). The loss of wing margin resulting from KD-
PI3K_68D overexpression was enhanced by loss-of-function
mutations in Notch such as N264-39 (Fig. 4K) and notchoid
(results not shown), demonstrating that PI3K_68D can also
interact genetically with the Notch signaling pathway. The
Notch-dependent loss of the wing margin was not enhanced by
WT-PI3K_68D (Fig. 4L).
We were unable to identify specific mutations within the
PI3K_68D gene among existing mutant stocks that mapped to
this region. However, a deficiency which deleted one copy of
the gene (Fig. 5), and hence presumably lowered the endoge-
nous levels of the protein, interacted with the DER and Notch
signaling pathway phenotypes in a manner similar to that for
FIG. 4. Genetic interactions between PI3K_68D transgene phenotypes and components of the Drosophila EGFR and Notch signaling pathways.
(A to C) At 25°C, expression of Gal4-69B alone produced an essentially wild-type wing (A), while expression of a KD-PI3K_68D transgene
produced only mild ectopic wing vein material (B) and expression of a WT-PI3K_68D transgene produced a small hole within the hinge region
(C). (D to F) One copy of an activated form of DER (Elp) alone had little effect on wing venation (D) but enhanced the formation of an ectopic
cross vein in flies expressing UAS-KD-PI3K_68D from 5 to 100% at 25°C (for n  81 flies and for two different KD-PI3K_68D insertions) (E) and
the loss of the anterior (and partial loss of the posterior) cross vein in flies expressing UAS-WT-PI3K_68D (F). (G to I) Expression of argos (aos),
a secreted inhibitor of DER, with Gal4-69B produced a narrower wing in which L4 and the anterior cross vein were missing (G). Coexpression
of KD-PI3K_68D rescued L4 and the anterior cross vein but resulted in the loss of the posterior cross vein (H). Coexpression of WT-PI3K_68D
enhanced the loss of wing veins (I). In addition to the loss of L4, the anterior cross vein, and the posterior cross vein, most of L3 and parts of L2
were deleted. Remnants of the latter veins, where present, occupied medial positions. (J to L) Loss-of-function mutations at the Notch locus (such
as N264-39) produce a characteristic notching of the wing margin at the anterior-posterior border (J). This was enhanced by expression of the
UAS-KD-PI3K_68D transgene (K). In a small proportion of Notch flies, more severe wing notching is obtained. Similarly 2% of flies expressing
catalytically inactive PI3K_68D at 25°C display a wing notching phenotype (Fig. 3E and F). Combinations of these more severe phenotypes
presumably account for the small proportion of flies showing more severe interactions (not shown). Expression of WT-PI3K-68D did not enhance
the loss-of-wing margin or the vein thickening of N264-39 (L). Flies were raised at 25°C. The wings shown are from female flies of genotypes
Gal4-69B/ (A), Gal4-69B/UAS-KD-PI3K_68D (B), UAS-WT-PI3K_68D/; Gal4-69B/ (C), Bc, EgfrElpE1/; Gal4-69B/ (D), Bc, EgfrElpE1/;
Gal4-69B, UAS-KD-PI3K_68D/ (E), UAS-WT-PI3K_68D/; Bc, EgfrElpE1/; Gal4-69B/ (F), Gal4-69B/UAS-aos (G), Gal4-69B, UAS-KD-
PI3K_68D/UAS-aos (H), UAS-WT-PI3K_68D/; Gal4-69B/UAS-aos (I), N264-39/; Gal4-69B/ (J), N264-39/; Gal4-69B, UAS-KD-PI3K_68D/
(K), and N264-39/UAS-WT-PI3K_68D; Gal4-69B/ (L).
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the catalytically inactive PI3K_68D transgenes. Hence,
Df(3L)vin3 enhanced the wing margin loss associated with a
Notch mutation and fully rescued the wing vein loss and shape
change characteristic of argos overexpression (Fig. 5). In con-
trast, a deletion at the cytological position 92E, termed
Dp110A, which specifically removes the class I PI3K, had no
effect on the Notch and argos phenotypes. These results sup-
port our assumption that the catalytically inactive PI3K_68D
acts in a dominant-negative manner and that the phenotypes it
generates reflect a disruption of processes in which the endog-
enous PI3K_68D is involved. In addition, Df(3L)vin3 sup-
pressed the loss-of-bristle phenotype generated by Gal4-ptc
WT-PI3K_68D, consistent with the deficiency decreasing the
level of class II PI3K activity (results not shown).
PI3K_68D can bind the Drk adaptor protein in vitro. In
order to investigate the mechanism by which PI3K_68D can
interact genetically with the DER signaling pathway, we ini-
tially looked for a direct interaction between PI3K_68D and
DER. Following coexpression of PI3K_68D and an activated
version of DER in adult flies, we were unable to identify the
Myc-tagged PI3K_68D in phosphotyrosine immunoprecipi-
tates of activated DER (results not shown). Analysis of the
PI3K_68D sequence had indicated a class II polyproline motif
within a region of low complexity towards the N terminus of
the molecule. This was predicted to act as a potential binding
site for SH3 domains (40). In fact, this sequence, PPPLPPR, is
identical to P1, one of the three proline-rich motifs within the
C-terminal region of SOS, a guanine nucleotide exchange fac-
tor that activates Ras (50). The polyproline motifs within SOS
bind the SH3 domains of Drk, the Drosophila homologue of
mammalian Grb2. Drk is an adaptor protein that contains a
phosphotyrosine binding SH2 domain flanked by two polypro-
line binding SH3 domains. Hence, Drk can link receptor ty-
rosine kinases with the activation of Ras and the MAPK path-
way. A further sequence within PI3K_68D, RMQPTNP,
located at amino acids 123 to 129 contains a basic residue N
terminal to the polyproline core and hence conforms to the
consensus for class I polyproline motifs (xxPxxP).
We therefore investigated whether the Myc-tagged wild-type
PI3K_68D expressed in adult flies could bind a GST-Drk fu-
sion protein. As a control, an activated version of DER was
also used. Both PI3K_68D and DER could associate with Drk
(Fig. 6A). The interaction with DER is presumably via an
interaction between the Drk SH2 domain and phosphotyrosine
FIG. 5. Genetic interactions between PI3K_68D deficiencies and components of the Drosophila EGFR and Notch signaling pathways. (Top)
Region of chromosome arm containing the PI3K_68D gene. Deficiency mapping by Southern hybridization showed that the PI3K_68D locus is
uncovered by the deficiencies Df(3L)vin3, Df(3L)vin4, Df(3L)vin6, and Df(3L)vin7 but excluded from Df(3L)vin2 and Df(3L)vin66, placing it at
	68D6 to 68E3-4. This region probably contains five lethal complementation groups (31), including the genes cyclin A and brachyenteron. The
chromosomal breakpoints of the vin deficiencies are from reference 1. (A to F) Notching of the wing margin by N264-39 (A) is enhanced by a
deficiency, Df(3L)vin3, which deletes the class II PI3K, PI3K_68D (B), but not by Dp110A, which removes the class I PI3K, PI3K_92E (C). Similarly,
the loss of the L4 wing vein on ectopic expression of argos (D) is rescued by Df(3L)vin3 (E) but unaffected by Dp110A (F). Crosses were performed
at 25°C. The wings shown are from female flies of genotypes N264-39/ (A), N264-39/; Df(3L)vin3/ (B), N264-39/; Dp110A/ (C), Gal4-69B,
UAS-aos/ (D), Gal4-69B, UAS-aos/Df(3L)vin3 (E), and Gal4-69B, UAS-aos/Dp110A (F).
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residues on DER. For PI3K_68D the interaction is predicted
to be via the polyproline motif(s) in the N terminus of
PI3K_68D and the SH3 domain(s) of Drk.
To investigate interactions mediated by these polyproline
motifs in PI3K_68D, an N-terminal fragment containing the
two polyproline motifs was generated and incubated with a
panel of SH3 domains from a number of Drosophila signaling
proteins. The N terminus of PI3K_68D showed a strong inter-
action only with the N-terminal SH3 domain of Drk. Weaker
interactions were also observed with both the C-terminal SH3
domain of Drk and the SH3 domain of H-spectrin (Fig. 6B).
No interactions were observed with the SH3 domains from a
number of other signaling proteins. These included Drosophila
phospholipase C and Src64B. The mammalian homologues of
these proteins have been reported to bind the EGFR, and
hence it is possible that their SH3 domains may localize inter-
acting molecules such that they can modify EGFR signaling.
Similarly, no interaction was detected with Drosophila p120
RasGAP, a negative regulator of Ras; with DAbl, a non-re-
ceptor tyrosine kinase; or with -spectrin, a cytoskeletal pro-
tein. Although the SH3 domains tested represented only a
small proportion of those present in Drosophila (90 have been
identified to date in the PFAM database [http://pfam.wustl
.edu/cgi-bin/getdesc?nameSH3]), these results clearly show
that there is specificity in the interaction between PI3K_68D
and the SH3 domains of Drk. To investigate further the con-
tributions made by the two SH3 domains of Drk in binding to
the N terminus of PI3K_68D, we used wild-type Drk and Drk
variants containing mutations in the highly conserved trypto-
phan residues (W36 in N-terminal SH3 and W189 in C-termi-
nal SH3) (50). Binding of Drk to the N terminus of PI3K_68D
was almost but not completely abolished by mutation of the
N-terminal SH3 domain (Fig. 7A, top panel). In contrast, al-
though binding was largely unaffected by mutation of the C-
FIG. 6. PI3K_68D can associate with the adaptor protein Drk in
vitro. (A) Extracts from 25 heat-shocked flies expressing Myc-tagged
PI3K_68D or DER were incubated with GST-Drk (20 
g). Bound
proteins equivalent to 1.5 flies (extracts) or 25 flies (pull-downs) were
resolved by electrophoresis on an SDS–8% polyacrylamide gel, trans-
ferred to nitrocellulose, and detected with the 9E10 antibody. (B) Bac-
terial extracts expressing a Myc-tagged N-terminal fragment of
PI3K_68D (20 
g) were incubated with GST alone (control) or with
the different GST-SH3 fusion proteins shown (20 
g of each). An
amount equivalent to 0.5 or 1% of each of the complexes bound to
glutathione-Sepharose beads was resolved on an SDS–12% polyacryl-
amide gel, transferred to nitrocellulose, and detected with the 9E10
antibody. Upper and middle panels, proteins associated with 100 ng
(upper) or 200 ng (middle) of GST-SH3 fusion proteins, respectively;
lower panel, Coomassie blue-stained gel of the different fusion pro-
teins (2 
g). Similar results were obtained in three separate experi-
ments.
FIG. 7. A polyproline motif within PI3K_68D mediates binding to
the SH3 domains of Drk. Bacterial extracts expressing Myc-tagged
wild-type or mutant N-terminal fragments of PI3K_68D were incu-
bated with the indicated GST-Drk fusion proteins (wild type or SH3
domain mutants) (20 
g). An amount equivalent to 0.5% of each of
the complexes (100 ng of fusion protein) bound to glutathione-Sepha-
rose beads was resolved on an SDS–12% polyacrylamide gel, trans-
ferred to nitrocellulose, and detected with the 9E10 antibody. The
lower panel in each section shows a Coomassie blue-stained gel of the
different fusion proteins (2.5 
g). Similar results were obtained in
three separate experiments.
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terminal SH3 domain, a complete loss of binding occurred only
when both domains were mutated. These results imply that the
N-terminal SH3 domain is primarily responsible for the inter-
action of Drk with PI3K_68D.
In order to identify the region within PI3K_68D responsible
for the interaction, the binding experiments were repeated
with proteins containing mutations in the critical proline and
arginine residues within either or both of the identified
polyproline motifs (RMQPTNP [PI] and PPPLPPR [PII]).
Binding of Drk to the N-terminal fragment of PI3K_68D was
largely unaffected by mutation of the first polyproline motif, PI
(Fig. 7A, second panel), but the interaction was completely
abolished by mutation of the second motif, PII (Fig. 7A, third
panel). These results imply that a single polyproline motif
within PI3K_68D can mediate the interaction with the adaptor
protein Drk in vitro, primarily through binding to the N-ter-
minal SH3 domain of Drk (Fig. 7A). To confirm these results,
the wild-type and mutant (PI and PII) N-terminal PI3K_68D
fragments were incubated with the isolated N- and C-terminal
Drk SH3 domains. Consistent with the results obtained with
the full-length Drk protein, binding of PI3K_68D to the N-
terminal SH3 domain of Drk was significantly greater than that
to the C-terminal SH3 domain and the interaction with both
the N- and C-terminal SH3 domains was completely abolished
when the PII polyproline motif was mutated (Fig. 7B). How-
ever, the results also implied that the C-terminal SH3 domain
of Drk when expressed alone could bind to the PI sequence, as
binding to the N-terminal fragment of PI3K_68D was consis-
tently reduced when this PI sequence was mutated (Fig. 7B).
Binding of the N-terminal fragment of PI3K_68D to the N-
terminal SH3 domain was unaffected by mutation of the PI
sequence (Fig. 7B), as was shown for the full-length Drk (Fig.
7A).
Genetic interactions between drk and a class II PI3K. In
order to address the in vivo significance of the interaction
observed between PI3K_68D and Drk, we looked for a genetic
interaction between the PI3K_68D transgenes and the drk mu-
tants. Since Drk acts downstream of the EGFR in wing vein
formation (19a), drk loss-of-function alleles would be antici-
pated to suppress ectopic wing veins. While a single copy of
either drk10626 or drke0A alone had no effect on wing vein
formation, the drke0A allele suppressed the formation of ec-
topic veins generated by KD-PI3K_68D (Table 2). In the drke0A
allele, His106 in the SH2 domain is mutated to Tyr (46). Since
this mutant is probably unable to bind to tyrosine-phosphory-
lated proteins but may still bind to SOS, it most likely has a
dominant-negative effect. Hence, it is likely to behave as a
stronger mutant allele than the drk10626 hypomorphic allele,
for which we were unable to observe an interaction. No inter-
action was observed between the drk mutant alleles and the
WT-PI3K_68D transgene; this may be because the normal wing
veins are less sensitive to perturbations than ectopic venation.
DISCUSSION
Ectopic expression of different classes of PI3Ks generates
distinct phenotypes. We embarked on a phenotypic analysis of
the class II Drosophila PI3K in order to identify developmental
systems and signaling pathways in which this class of PI3K
might be involved. In the absence of a mutation in the endog-
enous gene, we expressed PI3K_68D within Drosophila imagi-
nal disks and looked at the effects on the adult cuticle. Class I
and class II PI3Ks differ in their in vitro substrate specificity,
and hence their presumed lipid signal, and in their domain
structures, suggesting that they interact with different mole-
cules. Consistent with these biochemical and structural prop-
erties, expression of these distinct classes of PI3Ks in vivo
produced markedly different effects (Fig. 1).
Ectopic expression of the class I PI3K (PI3K_92E/Dp110)
within imaginal disks generated effects on growth and final
organ size without perturbing patterning. Moreover, this effect
was observed in all adult structures derived from regions of
Dp110 overexpression in the larval disks (37). In contrast, we
found that PI3K_68D affected pattern elements, particularly
the wing veins and margins (Fig. 3) and the sensory bristles on
the notum and head. Notably, while patterning of the adult
structures derived from the wing disk was affected by
PI3K_68D expression with Gal4-69B, the eye appeared pheno-
typically normal. Similarly, the EGFR ligand, vein, affects wing
veins but not the eye when expressed with Gal4-69B (reference
54 and data not shown). However, ectopic expression of a
number of other molecules with this driver, such as the EGFR
DER, argos, and PI3K_92E/Dp110, produced markedly rough
or enlarged eyes in addition to the wing effects (reference 54
and unpublished observations). The lack of a detectable phe-
notype in the eye could be due to a threshold effect. Hence, the
apparently ubiquitous effects of Dp110 expression may reflect
a more linear response of growth and/or cell size to growth
signals, while a threshold of signal may be required to trigger
the changes in patterning observed with PI3K_68D.
Genetic interactions between PI3K_68D and the DER sig-
naling pathway. The EGFR performs multiple functions in
Drosophila development (reviewed in references 14 and 55). In
imaginal disks, these functions include the specification of cell
fate and the survival of postmitotic cells (21). Consequently, a
variety of patterning defects are observed in the adult cuticle
following an earlier reduction in DER function. These include
the deletion of certain wing veins (principally L4 and the an-
terior cross vein), the duplication or elimination of specific
sensory bristles, roughened compound eyes, and shrunken or
missing ocelli (15). In the context of the wing imaginal disk,
DER is locally activated within all vein primordia by veinlet and
signals via the Ras-MAPK pathway to specify vein cell fate.
Thus, activated (6) or overexpressed DER produces ectopic
wing veins. Since expression of the catalytically inactive
PI3K_68D generates a similar phenotype, we looked for ge-
netic interactions between these molecules.
TABLE 2. Effect of drk alleles on catalytically inactive PI3K_68D
wing phenotypes
drk allele






drk10626 hypomorph 25 2
drke0A antimorph 3 0
a The single cross vein L2-L3 phenotype is as shown in Fig. 3D. Flies were
raised at 30°C. Values are for 100 flies of each genotype.
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A hypermorphic mutation in DER, known as Ellipse, was
able to enhance (Fig. 4E), and an antimorphic mutation in drk
was able to suppress (Table 2), the penetrance of the ectopic
cross vein phenotype produced by expressing the KD-
PI3K_68D transgene. Similarly, this transgene suppressed the
loss-of-veins phenotype induced by expression of the inhibitory
DER ligand, argos (Fig. 4H), while the vein loss was enhanced
by active PI3K_68D (Fig. 4I). These results suggest that
PI3K_68D may act antagonistically to the Ras-MAPK path-
way.
Examination of the sequence of PI3K_68D had previously
identified a putative SH3 binding motif (40). In vitro binding
studies demonstrated that this motif could interact with both
SH3 domains of Drk (Fig. 6 and 7), an adaptor protein that
links activated receptor tyrosine kinases such as DER to the
Ras-MAPK signaling pathway. While the binding was medi-
ated primarily by the N-terminal SH3 domain, the interaction
was completely abolished only by the mutation of both N- and
C-terminal SH3 domains. These results are consistent with the
conservation in sequence between the class II polyproline mo-
tif in PI3K_68D and the P1 sequence in SOS, which interacts
primarily but not exclusively with the N-terminal SH3 domain
of Drk. In SOS the P1 sequence represents the highest-affinity
site for Drk binding, but two further sequences may contribute
to this effect.
The EGFR family in mammals has also been shown to
recruit PI3Ks, although the mechanism involved is unclear.
Indeed, one of the most frequent alterations in the EGFR that
has been identified in human tumors (a deletion of exons 2 to
7, termed EGFRvIII, that results in ligand-independent recep-
tor activation) may exert its transforming activity through a
PI3K pathway (45). Recent results have indicated that the
EGFR may signal through class II, in addition to class I, PI3Ks.
First, only one of the four EGFR variants identified in mam-
mals, ErbB3, contains the specific YXXM motifs recognized by
the class IA adaptor subunit, yet EGF stimulation of PI3K
activity occurs in a number of cell types by an ErbB3-indepen-
dent mechanism (62). Second, DER, which is equally similar
structurally to the four mammalian EGFRs, lacks the YXXM
motifs required for association with the class I PI3K. Third,
overexpression of the class IA PI3K, Dp110, does not affect
wing venation (37) (Fig. 1). Recently the mammalian class II
PI3Ks, PI3K-C2 and PI3K-C2, have been identified in as-
sociation with the EGFRs ErbB-1/ErbB-2 (2), implicating
these mammalian class II PI3Ks in EGFR signaling. Within the
N terminus of PI3K-C2 there is a cluster of three class II
polyproline motifs analogous to the P1 to P3 sequences in SOS
that bind Drk (73). Further analysis of the interaction between
PI3K-C2 and the EGFR demonstrated that these sequences
were required for the interaction and that they appeared to
bind both the N- and C-terminal SH3 domains of the Drk
homologue Grb2 (73). However, while PI3K-C2 has been
reported to bind the activated EGFR, it lacks class II polypro-
line motifs. Furthermore, the third mammalian class II PI3K,
PI3K-C2, also lacks these sequences. These structural differ-
ences indicate that the interaction with Grb2 cannot be essen-
tial for the function of all class II PI3Ks. The single C. elegans
class II PI3K, however, contains multiple class II polyproline
motifs within the N terminus which might interact with the
Grb2 homologue, SEM-5. Hence, possession of a class II PI3K
containing a class II polyproline motif appears to be conserved
among multicellular organisms.
The Drk family of adaptor proteins has been shown to in-
teract with a number of different molecules. In addition to
interacting with the polyproline motifs in SOS primarily via the
N-terminal SH3 domain (50), the C-terminal SH3 domain can
bind the receptor substrate DOS via a novel motif (25). Both of
these interactions are anticipated to activate the Ras pathway.
In addition Drk/Grb2 family members have been reported to
interact with a number of molecules that negatively regulate
receptor tyrosine kinase signaling. Among these is c-Cbl, an E3
ubiquitin ligase that marks the EGFR for endocytosis and
hence degradation (71). In worms, a tyrosine kinase, ARK-1,
has also been shown to inhibit EGFR signaling, and it is de-
pendent upon the Grb2 homologue SEM-5 for this function
(32).
Our results suggest that PI3K_68D may negatively regulate
Ras-MAPK signaling downstream of the EGFR. However, this
cannot simply be due to PI3K_68D competing with SOS for
Drk and hence reducing signaling through SOS to Ras and the
MAPK pathway, because the wild-type and catalytically inac-
tive transgenes exerted opposite effects on modified EGFR
signaling (Fig. 4). Hence, the interaction with Drk may be a
mechanism for localization that allows the catalytic activity of
PI3K_68D to interfere with the Ras-MAPK pathway. The
3-phosphorylated lipids produced by PI3K_68D might induce
downregulation of DER-mediated Ras-MAPK signaling via
stimulation of, for example, an endocytic pathway. In this sit-
uation, expression of the catalytically inactive transgene could
displace the endogenous PI3K_68D but be unable to promote
endocytosis. This would enhance DER signaling at the plasma
membrane and hence wing vein formation. In mammalian
cells, receptor-mediated endocytosis has been shown to be
important in the downregulation of the ErbB1 EGFR in re-
sponse to its ligand EGF (reviewed in reference 56). Alterna-
tively, these lipids could interfere with the activation of EGFR
either directly or, for example, via the Notch signaling path-
way. While receptor-mediated endocytosis downregulates
EGF receptor signaling, this process appears to be required for
ligand-stimulated Notch signaling (57; reviewed in reference
56).
Clearly, it will be important to mutate the polyproline motif
in PI3K_68D and examine the effects in vivo.
Genetic interactions between PI3K_68D and the Notch sig-
naling pathway. Notch has multiple roles in development, par-
ticularly in the control of cell fate (reviewed in references 5 and
10). In mammals, a number of diseases, including T-cell lym-
phoma and mammary gland tumors, have been linked to mu-
tations in the human Notch genes (5). In Drosophila, loss-of-
function phenotypes for Notch include an increase in the
number of sensory bristles, a loss of wing margins, and thick-
ened veins. All of these phenotypes were also observed on
expression of catalytically inactive PI3K_68D. Furthermore, a
deficiency which deletes PI3K_68D (Fig. 5) or the expression of
KD-PI3K_68D (Fig. 4K) enhanced the wing notching pheno-
types generated by specific Notch mutations (Fig. 4J). Al-
though loss-of-function Notch mutations characteristically pro-
duce thicker veins, ectopic cross vein formation as observed for
KD-PI3K_68D expression (Fig. 3D) has been induced through
overexpression of an inhibitory version of Notch, the Notch
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extracellular domain (51). Furthermore, activated versions of
Notch (the Abruptex mutations) delete portions of the wing
veins. Notch frequently acts antagonistically to the EGFR in
cell fate specification (6, 19, 49; reviewed in reference 52).
Hence, these phenotypes indicate that PI3K_68D may be act-
ing downstream of, or parallel to, Notch in a pathway that
negatively regulates EGFR signaling. Alternatively, PI3K_68D
may influence Notch signaling through acting as a negative
regulator of the EGFR pathway. There are several potential
mechanisms for antagonism between these pathways. For ex-
ample, Notch negatively regulates veinlet transcription in in-
tervein cells and thus restricts veins to their characteristic
widths. If PI3K_68D is a component of this pathway, expres-
sion of the catalytically inactive transgene may allow ectopic
vein formation by relieving the inhibition on veinlet transcrip-
tion in intervein regions. Veinlet, like PI3K_68D, potently af-
fects EGFR signaling in the wing but not in the eye. Notch
signaling can also upregulate yan, an Ets transcriptional re-
pressor of multiple RTK signaling targets (53). In worms, re-
ceptor tyrosine kinase signaling can be inhibited through the
Notch-dependent induction of LIP-1, a MAPK phosphatase
(8). Conversely ebi and strawberry notch, two transcriptional
targets of EGFR signaling in flies, can suppress Notch signal-
ing (65).
Conclusions. The phenotypes that we have identified by
ectopic expression demonstrate that class I and class II PI3Ks
target distinct biological pathways. Whereas expression of the
class I PI3K affects growth, our results show that expression of
the class II PI3K perturbs patterning processes and may do so
via effects on signaling by EGFR and the Notch receptor.
Furthermore, the opposing phenotypes obtained with wild-
type and catalytically inactive versions of PI3K_68D indicate a
role for the class II PI3K-generated lipid signal in these pro-
cesses. While it is necessary to be cautious in interpreting
overexpression data, our results obtained by using deficiencies
are consistent with the catalytically inactive PI3K_68D acting
as a dominant-negative and disrupting processes in which the
endogenous PI3K_68D is involved.
The adult cuticle phenotypes that we have identified from
PI3K_68D expression can additionally be used for structure-
function analyses of PI3K_68D and to screen for mutations,
both within PI3K_68D itself and in genetically interacting mol-
ecules. We anticipate that these might include mutations in the
EGFR and Notch signaling pathways. The identification of
biological targets specific to class II PI3Ks will greatly facilitate
the elucidation of specific roles for this class of PI3Ks in sig-
naling pathways in both flies and mammals.
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